Abstract
It is well-established that adults with polycystic ovary syndrome (PCOS) have an increased prevalence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present review summarizes the existing evidence regarding the prevalence of traditional and non-traditional cardiometabolic risk factors in adolescents with PCOS.
Keywords: Polycystic ovary syndrome, adolescence, obesity, type 2 diabetes mellitus, hyperandrogenemia, anovulation.
Current Pharmaceutical Design
Title:Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome
Volume: 27 Issue: 36
Author(s): Anastasia Vatopoulou*, Maria-Eleni Dionelli, Alexis Papanikolaou and Sonia Grover
Affiliation:
- Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, 55133,Greece
Keywords: Polycystic ovary syndrome, adolescence, obesity, type 2 diabetes mellitus, hyperandrogenemia, anovulation.
Abstract: It is well-established that adults with polycystic ovary syndrome (PCOS) have an increased prevalence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present review summarizes the existing evidence regarding the prevalence of traditional and non-traditional cardiometabolic risk factors in adolescents with PCOS.
Export Options
About this article
Cite this article as:
Vatopoulou Anastasia *, Dionelli Maria-Eleni , Papanikolaou Alexis and Grover Sonia , Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome, Current Pharmaceutical Design 2021; 27 (36) . https://dx.doi.org/10.2174/1381612826666201127123357
DOI https://dx.doi.org/10.2174/1381612826666201127123357 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Circulating Levels of Uric Acid and Risk for Metabolic Syndrome
Current Diabetes Reviews Reduced Hemoglobin Levels Combined with an Increased Plasma Concentration of Vasoconstrictive endothelin-1 are Strongly Associated with Poor Outcome During Acute Ischemic Stroke
Current Neurovascular Research Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
Current Neuropharmacology Diabetes in Menopause: Risks and Management
Current Vascular Pharmacology Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Association Between Polycystic Ovary Syndrome and Metabolic Syndrome
Current Medicinal Chemistry Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine
Current Diabetes Reviews Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Autoimmune Hepatitis: Pathophysiology, Diagnosis and Pharmacological Therapy
Current Immunology Reviews (Discontinued) Glycogen Phosphorylase as a Target for Type 2 Diabetes: Synthetic, Biochemical, Structural and Computational Evaluation of Novel N-acyl-N´-(<i>β</i>-D-glucopyranosyl) Urea Inhibitors
Current Topics in Medicinal Chemistry HIV-1 Latency and Eradication: Past, Present and Future
Current HIV Research Signal Pathways Mediating Antidepressant and Antipsychotic Drugs on Neuronal Cell Survival
Current Medicinal Chemistry - Central Nervous System Agents What Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts
Current Alzheimer Research Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Development of Thiadiazole as an Antidiabetic Agent- A Review
Mini-Reviews in Medicinal Chemistry Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis
Current HIV Research From Structure – Based to Knowledge – Based Drug Design Through X-Ray Protein Crystallography: Sketching Glycogen Phosphorylase Binding Sites
Current Medicinal Chemistry